0001179110-18-010999.txt : 20180829
0001179110-18-010999.hdr.sgml : 20180829
20180829172038
ACCESSION NUMBER: 0001179110-18-010999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180828
FILED AS OF DATE: 20180829
DATE AS OF CHANGE: 20180829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leamon Christopher P
CENTRAL INDEX KEY: 0001509415
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35050
FILM NUMBER: 181044991
MAIL ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDOCYTE INC
CENTRAL INDEX KEY: 0001235007
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
BUSINESS PHONE: 7654637175
MAIL ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
4
1
edgar.xml
FORM 4 -
X0306
4
2018-08-28
0
0001235007
ENDOCYTE INC
ECYT
0001509415
Leamon Christopher P
3000 KENT AVE, SUITE A1-100
WEST LAFAYETTE
IN
47906
0
1
0
0
Vice President of Research
Common Stock
2018-08-28
4
M
0
12670
2.54
A
143051
D
Common Stock
2018-08-28
4
S
0
12670
20.0002
D
130381
D
Common Stock
2018-08-29
4
M
0
4696
2.54
A
135077
D
Common Stock
2018-08-29
4
S
0
4696
20.0000
D
130381
D
Stock Option (right to buy)
2.54
2018-08-28
4
M
0
12670
0
D
2019-03-05
Common Stock
12670
24696
D
Stock Option (right to buy)
2.54
2018-08-29
4
M
0
4696
0
D
2019-03-05
Common Stock
4696
20000
D
The stock options were exercised pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
Represents the sale of 12,670 shares in multiple transactions, ranging in price from $20.0000 to $20.0100, resulting in a weighted-average sale price per share of $20.0002. The reporting person will provide, upon request by SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
The shares were sold pursuant to a written plan specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
The option is fully vested and immediately exercisable.
/s/ Michael A. Sherman, Attorney-in-Fact for Christopher P. Leamon (power of attorney previously filed)
2018-08-29